Pi.bausch.com

BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD …

WEB2 | Page Pipeline Advancements • Received U.S. Food and Drug Administration (FDA) approval of the New Drug Application (NDA) for XIPERE™4 …

Actived: Just Now

URL: https://pi.bausch.com/globalassets/pdf/news-archive/bauschhealthpdf/20211102-news-release-bausch-health-announces-third-quarter-2021-results-final.pdf

FULL PRESCRIBING INFORMATION

WEB2 DOSAGE AND ADMINISTRATION Invert closed bottle and shake once to fill tip before instilling drops. Apply one drop of LOTEMAX ® SM into the conjunctival sac of the …

Category: Health Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES FOURTH …

WEB2 | Page • Reported revenue for the Solta business grew by 22% during the full year of 2021 compared to the full year of 2020 • Repaid debt by approximately $1.3 …

Category: Health Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES FIRST …

WEB2 | Page ompany Highlights Executing on ore usinesses and Advancing Pipeline • The ausch + Lomb/International segment comprised approximately 55% of the ompany’s …

Category: Health Go Health

The PROLENSA Effect PROLENSA is powered for efficacy at a …

WEBThe PROLENSA® Effect PROLENSA® (bromfenac ophthalmic solution) 0.07% is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of …

Category: Health Go Health

HIGHLIGHTS OF PRESCRIBING INFORMATION

WEBThe active ingredient is 1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluorotetradecane and is a semifluorinated alkane. It has a molecular formula of C14H17F13 and a molecular …

Category: Health Go Health

Discussing the cost of PROLENSA with your patients

WEBDiscussing the cost of PROLENSA®with your patients. Talking to your patients ahead of time about the cost of treatment is important. You may be able to minimize the calls you …

Category: Health Go Health

FULL PRESCRIBING INFORMATION

WEBLOTEMAX® (loteprednol etabonate ophthalmic ointment) 0.5% is a sterile ointment supplied in a tin tube with a pink polypropylene cap in the following size: NDC 24208 …

Category: Health Go Health

HIGHLIGHTS OF PRESCRIBING INFORMATION

WEBXiidra (lifitegrast ophthalmic solution) 5% (50 mg/mL) is supplied in a foil pouch containing 5 low-density polyethylene 0.2 mL single-use containers. Carton of 60 single-use …

Category: Health Go Health

REDUCE INFLAMMATION RELIEVE PAIN

WEBIndication LOTEMAX®GEL (loteprednol etabonate ophthalmic gel) 0.5% is used to treat inflammation and pain following eye surgery. Important Safety Information • ®LOTEMAX …

Category: Health Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES FIRST …

WEB2 | Page Pipeline Advancements • VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024%, received regulatory approval in South Korea, Brazil and …

Category: Health Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES SECOND …

WEB2 | Page • Refinanced $1.6 billion of 2024 Senior Secured Notes using net proceeds from newly issued $1.6 billion of 4.875% 2028 Senior Secured Notes and cash …

Category: Health Go Health

VALEANT Patient Assistance Program Application

WEB4. Have patient complete pages 1 and 2. Mail or fax the completed application form, requested documentation, and signed original prescription to: VALEANT PATIENT …

Category: Health Go Health

HIGHLIGHTS OF PRESCRIBING INFORMATION These …

WEB12.3 Pharmacokinetics The estimated maximum daily dose of ganciclovir administered as 1 drop, 5 times per day is 0.375 mg. Compared to maintenance doses of systemically …

Category: Health Go Health

A patient s guide to treatment with Visudyne (vertepor n for …

WEBA patient s guide to treatment with Visudyne ® (vertepor n for injection) Indication Visudyne ® (vertepor n for injection) is used along with laser light treatment to stop leaking from …

Category: Health Go Health

Investor Contact: Media Contact: BAUSCH HEALTH …

WEB2 | Page certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements.

Category: Health Go Health

FULL PRESCRIBING INFORMATION

WEBThe necessity or desirability of withdrawal of beta-adrenergic blocking agents prior to major surgery is controversial. Beta-adrenergic receptor blockade impairs the ability of the …

Category: Health Go Health

INC. ANNOUNCES FOURTH -QUARTER AND FULL YEAR 2020 …

WEB4 | Page Debt Management • Repaid debt by approximately $480 million in the fourth quarter of 2020 for a total of approximately $900 million in the full year of 2020 …

Category: Health Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES THIRD …

WEB2 | Page o Launched Ocuvite® Eye Performance vitamins in the United States, which are formulated to help protect the eye from digital device blue light and UV …

Category: Vitamin Go Health

BAUSCH HEALTH COMPANIES INC. ANNOUNCES FOURTH …

WEB2 | Page o Reported revenue in the ausch + Lomb/International segment increased by 2% in 2019 compared to 2018; revenue in this segment grew organically1,2 by 5% compared …

Category: Health Go Health

3819201 ScleralFil Preservative Free Saline Insert US

WEBCONTENTS: ScleralFil® preservative free saline solution is a sterile bu ered isotonic saline solution that has boric acid, sodium borate, and sodium chloride in …

Category: Health Go Health

xxx These highlights do not include all the information …

WEBFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for …

Category: Health Go Health